Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 2 |
STJ
St Jude Medical
STJ
|
+$235M |
| 3 |
JPMorgan Chase
JPM
|
+$211M |
| 4 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 65.39% |
| 2 | Technology | 5.81% |
| 3 | Healthcare | 5.36% |
| 4 | Financials | 4.29% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
PUT
Caterpillar
CAT
$360B
| $56.5M | 0.06% |
608,700
-102,100
| -14% | -$9.67M |
|
227
Palo Alto Networks
PANW
$306B
| $55.7M | 0.06% |
2,966,916
+1,933,614
| +187% | +$43.2M |
|
228
Teva Pharmaceuticals
TEVA
$45.1B
| $55.3M | 0.06% |
1,722,949
+596,713
| +53% | +$20.4M |
|
229
CALL
AT&T
T
$182B
| $55.3M | 0.06% |
1,761,450
-1,082,554
| -38% | -$34.1M |
|
230
PUT
Ulta Beauty
ULTA
$23.5B
| $55.2M | 0.06% |
193,500
+171,800
| +792% | +$47M |
|
231
PUT
Nike
NKE
$55B
| $55M | 0.06% |
987,200
-106,900
| -10% | -$5.91M |
|
232
CALL
VanEck Oil Services ETF
OIH
$1.97B
| $54.8M | 0.06% |
88,995
+82,815
| +1,340% | +$53.8M |
|
233
PUT
IBM
IBM
$235B
| $54.7M | 0.06% |
328,653
-137,340
| -29% | -$23M |
|
|
X
234
PUT
DELISTED
US Steel
X
| $53.7M | 0.06% |
1,587,800
-672,500
| -30% | -$23.9M |
|
235
Morgan Stanley
MS
$324B
| $53.6M | 0.06% |
1,251,309
-1,278,957
| -51% | -$56.8M |
|
236
Kimberly-Clark
KMB
$33B
| $53.4M | 0.06% |
405,909
-41,603
| -9% | -$5.25M |
|
237
Zimmer Biomet
ZBH
$18.4B
| $52.8M | 0.06% |
445,540
+198,619
| +80% | +$22.5M |
|
238
PUT
Advanced Micro Devices
AMD
$805B
| $52.7M | 0.06% |
3,620,500
+2,206,900
| +156% | +$28M |
|
|
MBLY
239
PUT
DELISTED
Mobileye N.V.
MBLY
| $52.4M | 0.06% |
853,800
+126,700
| +17% | +$6.09M |
|
240
Capital One
COF
$127B
| $52.2M | 0.06% |
602,374
-552,422
| -48% | -$49.2M |
|
241
Southern Company
SO
$100B
| $52.1M | 0.06% |
1,047,306
-255,187
| -20% | -$12.6M |
|
|
RHT
242
DELISTED
Red Hat Inc
RHT
| $52M | 0.06% |
601,310
+29,780
| +5% | +$2.37M |
|
243
Marathon Petroleum
MPC
$111B
| $51.9M | 0.06% |
1,026,642
-603,597
| -37% | -$30M |
|
244
DaVita
DVA
$12.1B
| $51M | 0.06% |
750,370
+625,990
| +503% | +$41.4M |
|
245
CALL
Wells Fargo
WFC
$268B
| $50.9M | 0.06% |
915,000
-471,100
| -34% | -$26.7M |
|
246
CALL
Qualcomm
QCOM
$192B
| $50.7M | 0.06% |
884,700
+181,900
| +26% | +$10.6M |
|
247
PUT
Verizon
VZ
$213B
| $50.6M | 0.06% |
1,038,400
-621,200
| -37% | -$31.2M |
|
248
CALL
Chipotle Mexican Grill
CMG
$46.9B
| $50.5M | 0.05% |
5,665,000
+450,000
| +9% | +$3.71M |
|
249
Kraft Heinz
KHC
$28.8B
| $50.4M | 0.05% |
554,786
-235,063
| -30% | -$21.2M |
|
|
ALXN
250
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $49.9M | 0.05% |
411,900
+312,200
| +313% | +$40.3M |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $6.63B of net new capital in Q1 2017, opening 571 new positions and adding to 2,784 existing holdings. Its largest new stake was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 70% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street Consumer Staples Select Sector SPDR ETF, an estimated $380M trimmed.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 571 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.